HSDT vs. ICU, PSTV, STRR, NUWE, TIVC, CTCX, CHEK, TNON, SINT, and HSCS
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include SeaStar Medical (ICU), Plus Therapeutics (PSTV), Star Equity (STRR), Nuwellis (NUWE), Tivic Health Systems (TIVC), Carmell (CTCX), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), and Heart Test Laboratories (HSCS). These companies are all part of the "medical equipment" industry.
Helius Medical Technologies vs.
Helius Medical Technologies (NASDAQ:HSDT) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations.
Helius Medical Technologies has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.02, meaning that its share price is 202% less volatile than the S&P 500.
Helius Medical Technologies received 19 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 55.56% of users gave Helius Medical Technologies an outperform vote.
Helius Medical Technologies presently has a consensus target price of $24.00, suggesting a potential upside of 4,360.97%. Given Helius Medical Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Helius Medical Technologies is more favorable than SeaStar Medical.
Helius Medical Technologies has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.
SeaStar Medical has a net margin of 0.00% compared to Helius Medical Technologies' net margin of -1,764.74%. SeaStar Medical's return on equity of 0.00% beat Helius Medical Technologies' return on equity.
18.6% of Helius Medical Technologies shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 5.1% of Helius Medical Technologies shares are held by insiders. Comparatively, 2.1% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, SeaStar Medical had 1 more articles in the media than Helius Medical Technologies. MarketBeat recorded 1 mentions for SeaStar Medical and 0 mentions for Helius Medical Technologies. Helius Medical Technologies' average media sentiment score of 0.00 beat SeaStar Medical's score of -0.27 indicating that Helius Medical Technologies is being referred to more favorably in the media.
Summary
Helius Medical Technologies beats SeaStar Medical on 13 of the 18 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Helius Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:HSDT) was last updated on 2/22/2025 by MarketBeat.com Staff
